Multimodal learning is widely used in automated early diagnosis of Alzheimer's disease. However, the current studies are based on an assumption that different modalities can provide more complementary information to help classify the samples from the public dataset Alzheimer's Disease Neuroimaging Initiative (ADNI). In addition, the combination of modalities and different tasks are external factors that affect the performance of multimodal learning. Above all, we summrise three main problems in the early diagnosis of Alzheimer's disease: (i) unimodal vs multimodal; (ii) different combinations of modalities; (iii) classification of different tasks. In this paper, to experimentally verify these three problems, a novel and reproducible multi-classification framework for Alzheimer's disease early automatic diagnosis is proposed to evaluate and verify the above issues. The multi-classification framework contains four layers, two types of feature representation methods, and two types of models to verify these three issues. At the same time, our framework is extensible, that is, it is compatible with new modalities generated by new technologies. Following that, a series of experiments based on the ADNI-1 dataset are conducted and some possible explanations for the early diagnosis of Alzheimer's disease are obtained through multimodal learning. Experimental results show that SNP has the highest accuracy rate of 57.09% in the early diagnosis of Alzheimer's disease. In the modality combination, the addition of Single Nucleotide Polymorphism modality improves the multi-modal machine learning performance by 3% to 7%. Furthermore, we analyse and discuss the most related Region of Interest and Single Nucleotide Polymorphism features of different modalities.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/TCBB.2022.3204619 | DOI Listing |
J Biochem Mol Toxicol
January 2025
Department of Medical Biochemistry, Faculty of Medicine, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey.
Neurodegenerative diseases are significant health concerns that have a profound impact on the quality and duration of life for millions of individuals. These diseases are characterized by pathological changes in various brain regions, specific genetic mutations associated with the disease, deposits of abnormal proteins, and the degeneration of neurological cells. As neurodegenerative disorders vary in their epidemiological characteristics and vulnerability of neurons, treatment of these diseases is usually aimed at slowing disease progression.
View Article and Find Full Text PDFInt J Geriatr Psychiatry
January 2025
Precision Neuroscience & Neuromodulation Program, Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Background: Alzheimer's disease (AD) is characterized by impaired inhibitory circuitry and GABAergic dysfunction, which is associated with reduced fast brain oscillations in the gamma band (γ, 30-90 Hz) in several animal models. Investigating such activity in human patients could lead to the identification of novel biomarkers of diagnostic and prognostic value. The current study aimed to test a multimodal "Perturbation-based" transcranial Alternating Current Stimulation-Electroencephalography (tACS)-EEG protocol to detect how responses to tACS in AD patients correlate with patients' clinical phenotype.
View Article and Find Full Text PDFSci Rep
January 2025
TauRx Therapeutics, Aberdeen, Scotland.
The purpose of this article is to infer patient level outcomes from population level randomized control trials (RCTs). In this pursuit, we utilize the recently proposed synthetic nearest neighbors (SNN) estimator. At its core, SNN leverages information across patients to impute missing data associated with each patient of interest.
View Article and Find Full Text PDFJ Neurol Neurosurg Psychiatry
January 2025
Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Background: Depression is often cited as a major modifiable risk factor for dementia, though the relative contributions of a true causal relationship, reverse causality and confounding factors remain unclear. This study applied a subset of the Bradford Hill criteria for causation to depression and dementia including strength of effect, specificity, temporality, biological gradient and coherence.
Methods: A total of 491 557 participants in UK Biobank aged between 40 and 69 at enrolment and followed up for a mean duration of 12.
Pharmacol Res
January 2025
Department of Clinical Pharmacy, Xiangtan Central Hospital (The affiliated hospital of Hunan university), Xiangtan 411100, China. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!